Search
Powered By HealthLine
Health Tools
 Acid Reflux Revention
 Info About The Large Intestine
 The Stomach and Small Intestine
 Check Symptoms for Acid Reflux
 Check IBD Symptoms
 The Facts About Infant Intestines
 Quiz: The Digestive System
 Ask A Questions About IBD
 Causes of Acid Reflux
 Ask A Question About Digestion
Featured Conditions
 Acid Reflux
 Acid Reflux
 Inflammatory Bowel Disease
 Diet & Exercise
 Cholesterol
 Diet & Exercise
 Cholesterol
 Inflammatory Bowel Disease
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Drug DescriptionSide Effects & Drug InteractionsWarnings & PrecautionsAdditional Info
Clinical PharmacologyOverdosage & ContraindicationsIndications & DosagePatient Info

Serevent Aerosol

[salmeterol xinafoate]


Patient Info
Information for Patients

See illustrated PATIENT’S INSTRUCTIONS FOR USE. SHAKE WELL BEFORE USING.

It is important that patients understand how to use SEREVENT Inhalation Aerosol appropriately and how it should be used in relation to other asthma or COPD medications they
are taking. Patients should be given the following information:

Text Continues Below



1. Shake well before using.

2. The action of SEREVENT Inhalation Aerosol may last up to 12 hours or longer. The recommended dosage (2 inhalations twice daily, morning and evening) should not be exceeded.

3. SEREVENT Inhalation Aerosol is not meant to relieve acute asthma or COPD symptoms and extra doses should not be used for that purpose. Acute symptoms should be treated with an inhaled, short-acting beta2-agonist such as albuterol (the physician should provide the patient with such medication and instruct the patient in how it should be used).

4. Patients should not stop SEREVENT therapy for asthma or COPD without
physician/provider guidance since symptoms may recur after discontinuation.

5. The physician should be notified immediately if any of the following situations occur, which may be a sign of seriously worsening asthma. Decreasing effectiveness of inhaled, short-acting beta2-agonists
Need for more inhalations than usual of inhaled, short-acting beta2-agonists Use of 4 or more inhalations per day of a short-acting beta2-agonist for 2 or more days consecutively Use of more than one 200-inhalation canister of an inhaled, short-acting beta2-agonist
(e.g., albuterol) in an 8-week period

6. SEREVENT Inhalation Aerosol should not be used as a substitute for oral or inhaled corticosteroids. The dosage of these medications should not be changed and they should not be stopped without consulting the physician, even if the patient feels better after initiating treatment with SEREVENT Inhalation Aerosol.

Page:  1 | 2 | 3 | 4 | 5 | Next >>







HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire